Navigation Links
Ambit Biosciences Announces Third Quarter 2013 Operating Results
Date:11/7/2013

sands) Three MonthsEnded September 30,Nine MonthsEnded September 30,2013201220132012Revenues

$

7,678$

4,282$

25,817$

14,689Operating expenses:Research and development

4,4848,16920,15330,120General and administrative

3,0761,2307,0494,533Gain on sale of kinase profiling services business

(2,500)(480)(2,500)(1,600)Total operating expenses

5,0608,91924,70233,053Income (loss) from operations

2,618(4,637)1,115(18,364)Other expenses, net

(8,687)(2,028)(10,326)(3,604)Consolidated net loss

$

(6,069)$

(6,665)$

(9,211)$

(21,968) Ambit Biosciences CorporationSelected Financial Information Condensed Consolidated Balance Sheets(in thousands) September 30,2013December 31,2012(unaudited)Cash and cash equivalents$

78,856$

17,481Other assets1,0941,948Property and equipment, net816560Total assets$

80,766$

19,989Accounts payable, accrued expenses and other liabilities

$

6,397$

12,923Deferred revenue—20,671Warrant liabilities15,62310,540Redeemable non-controlling interest—3,323Convertible preferred stock—170,778Stockholders' equity (deficit)58,746(198,246)Total liabilities and stockholders' equity$

80,766$

19,989 Ambit Contacts: Marcy Graham

Andrew McDonald, Ph.D.Executive Director, Investor Relations & Corp CommLifeSci Advisors, LLCAmbit Biosciences, Inc.

Founding Partner858-334-2125

646-597-6987mgraham@ambitbio.com

andrew@lifesciadvisors.com 


'/>"/>
SOURCE Ambit Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Ambit Announces Participation At 12th Annual BIO Investor Forum
2. Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
3. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
4. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
5. APAC Stem Cell Research & Therapy Market a “Growth Engine” for Region’s Scientific Ambitions Says A New Market Research Report at ReportsnReports.com
6. Astellas and Ambit Announce Data Presentations Highlighting Quizartinib at the American Society of Hematology 54th Annual Meeting
7. Ambit Biosciences to Present at Two Upcoming Investor Conferences
8. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
9. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
10. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
11. Juneau Biosciences Names Dr. Dinesh Patel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 31, 2015 , ... Ralco is honored to announce that it ... Fair to be held August 5-9 in Marshall. The Ralco Enrichment Center is an ... and how agriculture impacts their daily lives. This unique exhibit also features a birthing ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research ... on the current state of the global Propanol market with a focus on the ... Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... Divine Skin (OTC Bulletin Board: DSKX ) has ... its diverse consumer goods business and accelerate development through its ... RECORD 2010 REVENUE.  Divine Skin started the ... $1.9 million or 55 percent over 2009. ...
...  MedTRACK, an Informa business unit, and the world,s ... unveiled a premier partnering tool for the J.P. ... attending the conference find licensing, investment and acquisition ... Filter companies can quickly identify like-minded suitors in ...
... a privately held biotechnology company that develops next ... receive a milestone payment from Boehringer Ingelheim.  The ... agreement executed in October 2010 to discover, develop ... Re-Targeting (DART) platform.  The amount of the milestone ...
Cached Biology Technology:Another Successful Year at Divine Skin 2Another Successful Year at Divine Skin 3MedTRACK Unveils Partnering Tool for J.P. Morgan Healthcare Conference 2MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim 2
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that Huawei has selected ... solution for its stylish smartwatch. Huawei chose the ... reliability, low power and highly responsive human interface ... Huawei designers also required a classic round watch ...
(Date:7/21/2015)... July 21, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that it has filed provisional patent 62/192218 ... This invention highlights next generation ... an account, but also the user using unique ...
(Date:7/9/2015)... JOSE, Calif. , July 9, 2015  Synaptics ... interface solutions, announced today that it will report financial ... on Thursday, July 30, 2015 after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... Every creature has its place and role in the oceans ... may lead to more accurate models of ocean change. , ... niche for most animals and plants ?a shark, for example, ... have been relegated to an also-ran world of "functional redundancy" ...
... a rare disease in which patients develop multiple, benign skin ... throughout the body, according to a report in the May ... from the loss of a gene called CYLD, causing tumors ... indicated a role for CYLD in inflammation, but the mechanism ...
... When a faulty protein wreaks havoc in cells and ... finger at a wayward gene. Now scientists are learning ... gene is perfectly normal. The diseases can be caused ... not executed properly, leading to a lethal buildup of ...
Cached Biology News:Bacteria can help predict ocean change 2Gene first linked to rare disease may trigger skin cancer, other tumors 2Gene first linked to rare disease may trigger skin cancer, other tumors 3'Sticky' mice lead to discovery of new cause of neurodegenerative disease 2'Sticky' mice lead to discovery of new cause of neurodegenerative disease 3'Sticky' mice lead to discovery of new cause of neurodegenerative disease 4
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Request Info...
Biology Products: